Dr. Satyanarayana Chava: Formulation capacity is very fungible. So, we can use it for ARV, non-ARV, diabetes, cardiovascular. There are no challenges. Only the size of the batch determines which line we use.
This is from latest concall, but I am unable to understand why formulation capacity is very interchangeable ? I am not getting feel of this?
| Subscribe To Our Free Newsletter |
